Binaytara

05/17/2026

Community in action. 🌏🙏

Last month in Kathmandu, our Nepal team came together with 13 local organizations at a program organized by Engage Nepal, chaired by former U.S. Ambassador to Nepal, H.E. Scott H. DeLisi, and his wife Lisa DeLisi.

We are so grateful to call Engage Nepal both an institutional donor and a collaborative partner. Events like this fuel our mission and fill our hearts.💙

05/16/2026

Join us for a FREE community event designed for hemophilia patients, caregivers, and families in Washington on June 6, from 10am-11am! 💙

Hear from Kristin Maher, MD, PhD from Seattle Children’s Hospital as we discuss:
✔️ Recognizing bleeding symptoms
✔️ Current & emerging therapies, including gene therapy
✔️ Side-effect management & treatment decisions
✔️ Mental health and quality of life
✔️ Shared decision-making tools
✔️ Live Q&A with the physician speaker

This interactive in-person session is FREE to attend, with free parking available. Seating is limited to 40 attendees.

🎟️ RSVP today:
https://binaytara.org/projects/conferences/hemophilia-education-event

04/29/2026

At the Binaytara Spring Research Day 2026, Dr. Innocent H. Peter Uggh at Kilimanjaro Clinical Research Institute (KCRI) presented a community-led model to improve HPV vaccination access among out-of-school Maasai girls in Tanzania.

His work highlights a critical gap in global health: traditional school-based vaccination programs often miss the most vulnerable populations.

By leveraging trusted community structures like community health workers and Maasai Mamas, this model brings life-saving prevention directly to those who need it most.

Read more: https://binaytara.org/cancernews/article/a-community-led-model-for-cervical-cancer-prevention-in-tanzania

04/25/2026

Heading into National Nurses Month, we're spotlighting Bikesh Sah, a nurse at the Binaytara Health Clinic in Janakpur, , who received specialized training in GI Surgery and Ostomy Care. He returned with clinical skills and a deeper understanding of what patients truly need.

To every nurse, health educator, and care provider in our network: thank you. The work you do at the bedside and in the community is the foundation of everything we build together.

During National Nurses Month, we want to hear from YOU. Has a nurse, doctor, or health professional walked with you through something hard? Drop their name in the comments, or visit here to share a tribute: https://binaytara.org/news/health/the-backbone-of-cancer-control-an-interactive-tribute-to-nurses

04/24/2026

If you care about real-world impact in cancer care, this story matters.

Breakthrough therapies are transforming outcomes in relapsed diffuse large B-cell lymphoma (DLBCL)—but here’s the real question: What if patients can’t access them?

In this powerful, case-based perspective, Dr. Nandita Khera explores a critical gap: innovation alone isn’t enough—access determines outcomes.

These challenges aren’t theoretical—they’re happening every day.

👉 You’re just one click away from understanding what needs to change: https://binaytara.org/cancernews/article/bridging-the-access-divide-in-relapsed-dlbcl-lessons-from-james-s-journey

Relapsed diffuse large B-cell lymphoma treatments like CAR-T and bispecific antibodies offer hope, but access barriers remain. Learn how coordinated care models can improve equitable treatment delivery.

04/24/2026

If you care about improving access, outcomes, and equity in cancer care, this is worth your time.

What if the biggest breakthroughs in breast cancer care never reached most patients? That’s the real challengeand opportunity highlighted at SABCS 2025.

Authored by Dr. Sara Zhukovsky and Dr. Christos Vaklavas, this article explores practical, scalable strategies to improve access, adherence, and equity in real-world care.

🚨Just one click away from practical strategies to improve cancer care and equity today: https://binaytara.org/cancernews/article/real-world-impact-applying-sabcs-2025-advances-in-community-oncology

Explore how SABCS 2025 innovations—risk-based screening, digital adherence tools, and survivorship platforms—are improving breast cancer care and equity in community oncology settings.

04/23/2026

☕Starbucks: 250,000 square feet of new office space in Nashville.
🧬Binaytara: $250,000 in hematology research funding in Nashville at our next Impact Pitch.

Coincidence? Absolutely.

But given how much caffeine fuels cancer researchers… we’re calling it a collaboration opportunity!

Submit to the National Summit on Hematologic Cancers in Nashville, and you could be competing for $250,000 in research funding: https://abstracts.binaytara.org/conference/2026-national-summit-on-hematologic-cancers-abstract

Let’s turn great ideas (and great coffee) into real impact.

04/23/2026

Thank you to Eighth Square Studio for capturing the energy, connection, and heart of our conference and our Annual Gala. From meaningful conversations to unforgettable moments of celebration, these images help tell the story of our mission and the community behind it. We’re grateful for their partnership and artistry.

Learn more about their impactful work at www.eighthsquarestudio.com

04/22/2026

Congratulations to Dr. Hetty Carraway of Cleveland Clinic on being named a 2026 Binaytara Distinguished Faculty Award recipient!

A nationally recognized leader in hematologic malignancies, Dr. Carraway has played a pivotal role in shaping Binaytara’s National Summit on Hematologic Cancers—transforming it into a premier forum for tackling complex clinical decisions where guidelines fall short.

We are especially excited to highlight her continued leadership as a Conference Chair for the 2026 National Summit on Hematologic Cancers in Nashville, where she will join an exceptional group of experts to help define the next generation of standards in leukemia, lymphoma, and multiple myeloma care.

Submit your abstract by August 15 and join us at our National Summit on Hematologic Cancers: https://binaytara.org/projects/conferences/2026-national-summit-on-hematologic-cancers

📍 Music City Center, Nashville, TN
📅 October 16–17, 2026

04/20/2026

Breast cancer care is entering a new era, and 2025 made that clear.

From antibody–drug conjugates (ADCs) moving into earlier, potentially curative settings to the rise of oral SERDs and mutation-guided therapy, this year’s data are already reshaping how oncologists approach treatment in 2026.

Read the full breakdown of SABCS 2025’s most practice-changing updates and what they mean for clinicians and patients: https://binaytara.org/cancernews/article/top-clinical-takeaways-from-sabcs-2025

SABCS 2025 introduced major breast cancer advances, including earlier use of antibody–drug conjugates, oral SERDs for endocrine resistance, and mutation-guided therapy strategies shaping oncology practice in 2026.